Combination CFTR modulator therapy in children and adults with cystic fibrosis

Lancet Respir Med. 2021 Jul;9(7):677-679. doi: 10.1016/S2213-2600(21)00176-4. Epub 2021 May 6.

Authors

Jennifer S Guimbellot¹, Jennifer L Taylor-Cousar²

Affiliations

¹ Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
² Division of Pulmonary, Critical Care, and Sleep Medicine, and Division of Pediatric Pulmonary Medicine, National Jewish Health, Denver, CO 80206, USA. Electronic address: [email protected].

PMID: 33965001
DOI: 10.1016/S2213-2600(21)00176-4

No abstract available

Publication types

Comment

MeSH terms

Adult
Aminophenols / therapeutic use
Child
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis* / drug therapy
Humans
Quinolones* / therapeutic use

Substances

Aminophenols
CFTR protein, human
Quinolones
Cystic Fibrosis Transmembrane Conductance Regulator